BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 17491330)

  • 1. [Pathogenesis of axonal Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 2007 Jan; 47(1):1-7. PubMed ID: 17491330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
    Yuki N; Odaka M
    Curr Opin Neurol; 2005 Oct; 18(5):557-61. PubMed ID: 16155440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate mimicry of Campylobacter jejuni lipooligosaccharide is critical for the induction of anti-GM1 antibody and neuropathy.
    Shu XM; Cai FC; Zhang XP
    Muscle Nerve; 2006 Feb; 33(2):225-31. PubMed ID: 16270308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate mimicry: a new paradigm of autoimmune diseases.
    Yuki N
    Curr Opin Immunol; 2005 Dec; 17(6):577-82. PubMed ID: 16229995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.
    Koga M; Gilbert M; Takahashi M; Li J; Koike S; Hirata K; Yuki N
    J Infect Dis; 2006 Feb; 193(4):547-55. PubMed ID: 16425134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures.
    Watanabe K; Kim S; Nishiguchi M; Suzuki H; Watarai M
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):121-7. PubMed ID: 16051063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside.
    Yuki N; Yamada M; Koga M; Odaka M; Susuki K; Tagawa Y; Ueda S; Kasama T; Ohnishi A; Hayashi S; Takahashi H; Kamijo M; Hirata K
    Ann Neurol; 2001 Jun; 49(6):712-20. PubMed ID: 11409422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
    Komagamine T; Yuki N
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial infections in Guillain-Barré and Fisher syndromes.
    Yuki N; Koga M
    Curr Opin Neurol; 2006 Oct; 19(5):451-7. PubMed ID: 16969154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.
    Funakoshi K; Koga M; Takahashi M; Hirata K; Yuki N
    J Neurol Sci; 2006 Jul; 246(1-2):163-8. PubMed ID: 16600306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human gangliosides and bacterial lipo-oligosaccharides in the development of autoimmune neuropathies.
    Yuki N
    Methods Mol Biol; 2010; 600():51-65. PubMed ID: 19882120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM1 antibody in Guillain-Barre syndrome after Campylobacter jejuni infection.
    Tang J; Yuan J; Hao H
    Chin Med J (Engl); 1995 Apr; 108(4):262-4. PubMed ID: 7789212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
    Rees JH; Gregson NA; Hughes RA
    Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.